COVID-19: NAFDAC approves Pfizer vaccine for Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved Pfizer COVID-19 vaccine for use in Nigeria.
The Director-General of the agency, Mojisola Adeyeye announced this during a virtual meeting on Friday in Abuja, explaining the vaccine is for emergency use.
NAFDAC’s approval comes months after the quality control agency approved the use of the Oxford-Astrazeneca jabs.
Before now, Nigeria procured Oxford/AstraZeneca COVID-19 vaccine, which is being administered across the country currently to check the spread of coronavirus.
Earlier in March, Nigeria received about four million doses of AstraZeneca/Oxford COVID-19 vaccine shipped into the country through the Nnamdi Azikiwe International Airport.
It flagged off the vaccination exercise with a medical doctor, Dr. Cyprian Nyong, of the National Hospital, Abuja, being the first to receive the jab of the AstraZeneca/Oxford COVID-19 vaccines.